Freedberg KA - Search Results

1

Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.

Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA; ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA); CEPAC International investigators. Losina E, et al. Among authors: freedberg ka. PLoS Med. 2009 Oct;6(10):e1000173. doi: 10.1371/journal.pmed.1000173. Epub 2009 Oct 27. PLoS Med. 2009. PMID: 19859538 Free PMC article.

2

The cost-effectiveness of liver biopsy in rheumatoid arthritis patients treated with methotrexate.

Bergquist SR, Felson DT, Prashker MJ, Freedberg KA. Bergquist SR, et al. Among authors: freedberg ka. Arthritis Rheum. 1995 Mar;38(3):326-33. doi: 10.1002/art.1780380306. Arthritis Rheum. 1995. PMID: 7880186

3

Validating literature-based models with direct clinical trial results: the cost-effectiveness of secondary prophylaxis for PCP in AIDS patients.

Freedberg KA, Hardy WD, Holzman RS, Tosteson AN, Craven DE. Freedberg KA, et al. Med Decis Making. 1996 Jan-Mar;16(1):29-35. doi: 10.1177/0272989X9601600110. Med Decis Making. 1996. PMID: 8717596

4

Prophylaxis for disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS: a cost-effectiveness analysis.

Freedberg KA, Cohen CJ, Barber TW. Freedberg KA, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Aug 1;15(4):275-82. doi: 10.1097/00042560-199708010-00005. J Acquir Immune Defic Syndr Hum Retrovirol. 1997. PMID: 9292586

5

The cost-effectiveness of fluconazole prophylaxis against primary systemic fungal infections in AIDS patients.

Scharfstein JA, Paltiel AD, Freedberg KA. Scharfstein JA, et al. Among authors: freedberg ka. Med Decis Making. 1997 Oct-Dec;17(4):373-81. doi: 10.1177/0272989X9701700402. Med Decis Making. 1997. PMID: 9343795

6

The cost-effectiveness of preventing AIDS-related opportunistic infections.

Freedberg KA, Scharfstein JA, Seage GR 3rd, Losina E, Weinstein MC, Craven DE, Paltiel AD. Freedberg KA, et al. JAMA. 1998 Jan 14;279(2):130-6. doi: 10.1001/jama.279.2.130. JAMA. 1998. PMID: 9440663

7

A Monte Carlo simulation of advanced HIV disease: application to prevention of CMV infection.

Paltiel AD, Scharfstein JA, Seage GR 3rd, Losina E, Goldie SJ, Weinstein MC, Craven DE, Freedberg KA. Paltiel AD, et al. Among authors: freedberg ka. Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S93-105. doi: 10.1177/0272989X98018002S11. Med Decis Making. 1998. PMID: 9566470

8

The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.

Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. Goldie SJ, et al. Among authors: freedberg ka. Ann Intern Med. 1999 Jan 19;130(2):97-107. doi: 10.7326/0003-4819-130-2-199901190-00003. Ann Intern Med. 1999. PMID: 10068381

9

Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion.

Freedberg KA, Paltiel AD. Freedberg KA, et al. Pharmacoeconomics. 1998 Aug;14(2):165-74. doi: 10.2165/00019053-199814020-00005. Pharmacoeconomics. 1998. PMID: 10186457 Review.

10

The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men.

Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. Goldie SJ, et al. Among authors: freedberg ka. JAMA. 1999 May 19;281(19):1822-9. doi: 10.1001/jama.281.19.1822. JAMA. 1999. PMID: 10340370

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

363 results

Search Page

Filters